These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19773758)

  • 1. Evaluation of bowel cancer registration data in England, 1996-2004.
    Jones AM; Morris E; Thomas J; Forman D; Melia J; Moss SM
    Br J Cancer; 2009 Oct; 101(8):1269-73. PubMed ID: 19773758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why did treatment rates for colorectal cancer in south east England fall between 1982 and 1988? The effect of case ascertainment and registration bias.
    Pollock AM; Benster R; Vickers N
    J Public Health Med; 1995 Dec; 17(4):419-28. PubMed ID: 8639341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme.
    Morris EJ; Whitehouse LE; Farrell T; Nickerson C; Thomas JD; Quirke P; Rutter MD; Rees C; Finan PJ; Wilkinson JR; Patnick J
    Br J Cancer; 2012 Aug; 107(5):757-64. PubMed ID: 22850549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests.
    Logan RF; Patnick J; Nickerson C; Coleman L; Rutter MD; von Wagner C;
    Gut; 2012 Oct; 61(10):1439-46. PubMed ID: 22156981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced risk of emergency admission for colorectal cancer associated with the introduction of bowel cancer screening across England: a retrospective national cohort study.
    Geraghty J; Shawihdi M; Devonport E; Sarkar S; Pearson MG; Bodger K
    Colorectal Dis; 2018 Feb; 20(2):94-104. PubMed ID: 28736972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the UK colorectal cancer screening pilot studies on incidence, stage distribution and mortality trends.
    McClements PL; Madurasinghe V; Thomson CS; Fraser CG; Carey FA; Steele RJ; Lawrence G; Brewster DH
    Cancer Epidemiol; 2012 Aug; 36(4):e232-42. PubMed ID: 22425027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer incidence trends by tumour location among adults of screening-age in England: a population-based study.
    Granger SP; Preece RAD; Thomas MG; Dixon SW; Chambers AC; Messenger DE
    Colorectal Dis; 2023 Sep; 25(9):1771-1782. PubMed ID: 37553121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of colorectal cancer: the 21-year experience of a specialised registry.
    Ponz de Leon M; Rossi G; di Gregorio C; De Gaetani C; Rossi F; Ponti G; Pecone L; Pedroni M; Roncucci L; Pezzi A; Benatti P
    Intern Emerg Med; 2007 Dec; 2(4):269-79. PubMed ID: 18060471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
    Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsite- and stage-specific colorectal cancer trends in Estonia prior to implementation of screening.
    Innos K; Reima H; Baburin A; Paapsi K; Aareleid T; Soplepmann J
    Cancer Epidemiol; 2018 Feb; 52():112-119. PubMed ID: 29294434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of colorectal cancer: what can we learn from the New Zealand Cancer Registry?
    Keating J; Pater P; Lolohea S; Wickremesekera K
    N Z Med J; 2003 May; 116(1174):U437. PubMed ID: 12766783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers.
    Gill MD; Bramble MG; Hull MA; Mills SJ; Morris E; Bradburn DM; Bury Y; Parker CE; Lee TJ; Rees CJ
    Br J Cancer; 2014 Nov; 111(11):2076-81. PubMed ID: 25247322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ongoing case-control study to evaluate the NHS Bowel Cancer Screening Programme.
    Massat NJ; Sasieni PD; Parmar D; Duffy SW
    BMC Cancer; 2014 Dec; 14():945. PubMed ID: 25495609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer incidence and survival by sub-site and stage of diagnosis: a population-based study at the advent of national screening.
    McDevitt J; Comber H; Walsh PM
    Ir J Med Sci; 2017 Feb; 186(1):113-121. PubMed ID: 27752924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Population-based incidence rates of colorectal neoplasms (2000 - 2006) - has systematic colonoscopy screening an impact on incidence? A combined analysis of cancer registry data of the Federal States of Bremen, Hamburg, Saarland and Schleswig-Holstein].
    Waldmann A; Eberle A; Hentschel S; Holleczek B; Katalinic A
    Z Gastroenterol; 2010 Dec; 48(12):1358-66. PubMed ID: 21125511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of increasing colorectal cancer screening uptake in Wolverhampton, UK: an exploratory study.
    Anand V; Gwinnett J; Phillips A
    Public Health; 2012 Sep; 126 Suppl 1():S44-S46. PubMed ID: 22769598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994.
    Ji BT; Devesa SS; Chow WH; Jin F; Gao YT
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):661-6. PubMed ID: 9718217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1992-1997.
    Cheng X; Chen VW; Steele B; Ruiz B; Fulton J; Liu L; Carozza SE; Greenlee R
    Cancer; 2001 Nov; 92(10):2547-54. PubMed ID: 11745188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.